Oragenics, Inc. (OGEN) announced on Monday that James Kelly, a Neurologist, has been appointed as its chief medical officer.
Kelly will be responsible for supervising the upcoming Phase II clinical trial of the company's primary drug candidate ONP-002.
Before this role, Kelly was the executive director of the Marcus Institute for Brain Health and a Professor of Neurology at the University of Colorado Anschutz Medical Campus in Aurora, Colorado.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.